Centivo stock

Centivo Stock

HealthTech
Founded: 2017Funding to Date: $148Mhttps://www.centivo.com

Centivo offers self-funded health plans designed to make healthcare more affordable for both employees and employers. The company allows employers to provide their workforce with user-friendly, cost-effective, and predictable healthcare options. Centivo enhances the member experience by providing a variety of benefit choices, including proprietary primary care-centered models and traditional networks. This enables self-funded employers to support the sustainable livelihoods of their employees.

Investors Include:

Bain Capital Ventures, Maverick Ventures, Global Public Offering Fund, Rand Capital BDC, Bessemer Venture Partners, Alumni Ventures, Eight Roads, MemorialCare Innovation Fund, James Foreman, Ingleside Investors, F-Prime Capital, Parkway Venture Capital, Valspring Capital, JP Morgan Chase, B Capital Group, Oxeon Partners, Socium Ventures, Trinity Capital, Define Ventures, Kenneth Goulet, Kevin Hill, HarbourVest Partners, Morgan Health, Cox Enterprises, Cone Health.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Management Team

Ashok SubramanianCo-Founder, Chief Executive Officer & Board Member
Dallas ScripPresident of TPA Services & Chief Delivery Officer
Wayne Jenkins MDChief Medical Officer
Ryan MooreChief Revenue Officer
Frank PedersenChief Marketing Officer
Alan CohenCo-Founder & Chief Product Officer
Stephanie ArgentineChief People Officer & Head of Legal Affairs
Gillian PrintonSenior Growth Leader, National Accounts
Tina PassariellaVice President of Finance and Administration
Enrique OlivaresChief Technology Officer
Stuart RothCo-Founder & Chief Business Officer

Board Members

Timothy HoweBoard Member
Jonathan LimBoard Member
Ambar BhattacharyyaBoard Member
Yumin ChoiBoard Member
James ForemanBoard Member
Karen PageBoard Member

Centivo’s stock FAQs

Other HealthTech Companies in Collective's mid-stage Target Portfolio.

A2 Bio stock
Aardvark Therapeutics stock
AcuityMD stock
Alamar Biosciences stock
Alterome Therapeutics stock
Arbor Biotechnologies stock
Attralus stock
Be Biopharma stock
Bluejay Therapeutics stock
Brightside Health stock
Capstan Therapeutics stock
Carrum Health stock
Casana stock
Cellanome stock
Chroma Medicine stock
Conformal stock
Convergent Therapeutics stock
Covera Health stock
Detect stock
Dewpoint Therapeutics stock
Dispatch Biotherapeutics stock
Egenesis stock
Elektrofi stock
Engrail Therapeutics stock
Equip stock
Firefly Health stock
Flare Therapeutics stock
Florence stock
FogPharma stock
Foresight Mental Health stock
Frontier Medicines stock
Genesis Therapeutics stock
Graviton BioScience stock
Hexagon Bio stock
Iambic Therapeutics stock
IDRx stock
Inceptive stock
Infinitus Systems stock
KSQ stock
Levels stock
LifeMine stock
LightForce stock
Loyal stock
Luna Physical Therapy stock
Lycia Therapeutics stock
Marea stock
Medallion stock
Nalu Medical stock
Neuron23 stock
NextPoint stock
OrsoBio stock
Ossium Health stock
Ostro stock
Overjet stock
Pager stock
Paradigm stock
Paradromics stock
Pathalys Pharma stock
Pelago stock
Pomelo Care stock
Rad AI stock
ReCode Therapeutics stock
Regard stock
Rivus Pharmaceuticals stock
Route 92 stock
SalioGen Therapeutics stock
Santa Ana Bio stock
Seismic Therapeutic stock
Sionna stock
SmarterDx stock
SmithRx stock
Strand Therapeutics stock
Suki stock
Syllable stock
Synchron stock
Synthekine stock
Third Arc Bio stock
Tome Biosciences stock
Tomorrow Health stock
Triveni Bio stock
Two Chairs stock
Unlearn stock
Vanqua Bio stock
Verse Medical stock
Viome Life Sciences stock
Vizgen stock

Companies backed by the same VC's

Abridge stock
Alloy stock
Axonius stock
BigID stock
Coast stock
Databook stock
Devo stock
Digits stock
Discord stock
EvenUp stock
Florence stock
GlossGenius stock
Guild Education stock
Hinge Health stock
HomeLight stock
Seismic Therapeutic stock
SmarterDx stock